Myeloid growth factors, version 2.2017

Jeffrey Crawford, Pamela Sue Becker, James O. Armitage, Douglas W. Blayney, Julio Chavez, Peter Curtin, Shira Dinner, Thomas Fynan, Ivana Gojo, Elizabeth A. Griffiths, Shannon Hough, Dwight D. Kloth, David J. Kuter, Gary H. Lyman, Mary Mably, Sudipto Mukherjee, Shiven Patel, Lia E. Perez, Adam Poust, Raajit Rampal & 12 others Vivek Roy, Hope S. Rugo, Ayman A. Saad, Lee Schwartzberg, Sepideh Shayani, Mahsa Talbott, Saroj Vadhan-Raj, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, Jennifer L. Burns, Lenora Pluchino

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.

Original languageEnglish (US)
Pages (from-to)1520-1541
Number of pages22
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Intercellular Signaling Peptides and Proteins
Chemotherapy-Induced Febrile Neutropenia
Febrile Neutropenia
Neutropenia
Patient Care
Guidelines
Drug Therapy
Incidence

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Crawford, J., Becker, P. S., Armitage, J. O., Blayney, D. W., Chavez, J., Curtin, P., ... Pluchino, L. (2017). Myeloid growth factors, version 2.2017. JNCCN Journal of the National Comprehensive Cancer Network, 15(12), 1520-1541. https://doi.org/10.6004/jnccn.2017.0175

Myeloid growth factors, version 2.2017. / Crawford, Jeffrey; Becker, Pamela Sue; Armitage, James O.; Blayney, Douglas W.; Chavez, Julio; Curtin, Peter; Dinner, Shira; Fynan, Thomas; Gojo, Ivana; Griffiths, Elizabeth A.; Hough, Shannon; Kloth, Dwight D.; Kuter, David J.; Lyman, Gary H.; Mably, Mary; Mukherjee, Sudipto; Patel, Shiven; Perez, Lia E.; Poust, Adam; Rampal, Raajit; Roy, Vivek; Rugo, Hope S.; Saad, Ayman A.; Schwartzberg, Lee; Shayani, Sepideh; Talbott, Mahsa; Vadhan-Raj, Saroj; Vasu, Sumithira; Wadleigh, Martha; Westervelt, Peter; Burns, Jennifer L.; Pluchino, Lenora.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 12, 01.12.2017, p. 1520-1541.

Research output: Contribution to journalReview article

Crawford, J, Becker, PS, Armitage, JO, Blayney, DW, Chavez, J, Curtin, P, Dinner, S, Fynan, T, Gojo, I, Griffiths, EA, Hough, S, Kloth, DD, Kuter, DJ, Lyman, GH, Mably, M, Mukherjee, S, Patel, S, Perez, LE, Poust, A, Rampal, R, Roy, V, Rugo, HS, Saad, AA, Schwartzberg, L, Shayani, S, Talbott, M, Vadhan-Raj, S, Vasu, S, Wadleigh, M, Westervelt, P, Burns, JL & Pluchino, L 2017, 'Myeloid growth factors, version 2.2017', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 12, pp. 1520-1541. https://doi.org/10.6004/jnccn.2017.0175
Crawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P et al. Myeloid growth factors, version 2.2017. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Dec 1;15(12):1520-1541. https://doi.org/10.6004/jnccn.2017.0175
Crawford, Jeffrey ; Becker, Pamela Sue ; Armitage, James O. ; Blayney, Douglas W. ; Chavez, Julio ; Curtin, Peter ; Dinner, Shira ; Fynan, Thomas ; Gojo, Ivana ; Griffiths, Elizabeth A. ; Hough, Shannon ; Kloth, Dwight D. ; Kuter, David J. ; Lyman, Gary H. ; Mably, Mary ; Mukherjee, Sudipto ; Patel, Shiven ; Perez, Lia E. ; Poust, Adam ; Rampal, Raajit ; Roy, Vivek ; Rugo, Hope S. ; Saad, Ayman A. ; Schwartzberg, Lee ; Shayani, Sepideh ; Talbott, Mahsa ; Vadhan-Raj, Saroj ; Vasu, Sumithira ; Wadleigh, Martha ; Westervelt, Peter ; Burns, Jennifer L. ; Pluchino, Lenora. / Myeloid growth factors, version 2.2017. In: JNCCN Journal of the National Comprehensive Cancer Network. 2017 ; Vol. 15, No. 12. pp. 1520-1541.
@article{31e65a929b1b442c939ab40da9544900,
title = "Myeloid growth factors, version 2.2017",
abstract = "Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.",
author = "Jeffrey Crawford and Becker, {Pamela Sue} and Armitage, {James O.} and Blayney, {Douglas W.} and Julio Chavez and Peter Curtin and Shira Dinner and Thomas Fynan and Ivana Gojo and Griffiths, {Elizabeth A.} and Shannon Hough and Kloth, {Dwight D.} and Kuter, {David J.} and Lyman, {Gary H.} and Mary Mably and Sudipto Mukherjee and Shiven Patel and Perez, {Lia E.} and Adam Poust and Raajit Rampal and Vivek Roy and Rugo, {Hope S.} and Saad, {Ayman A.} and Lee Schwartzberg and Sepideh Shayani and Mahsa Talbott and Saroj Vadhan-Raj and Sumithira Vasu and Martha Wadleigh and Peter Westervelt and Burns, {Jennifer L.} and Lenora Pluchino",
year = "2017",
month = "12",
day = "1",
doi = "10.6004/jnccn.2017.0175",
language = "English (US)",
volume = "15",
pages = "1520--1541",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "12",

}

TY - JOUR

T1 - Myeloid growth factors, version 2.2017

AU - Crawford, Jeffrey

AU - Becker, Pamela Sue

AU - Armitage, James O.

AU - Blayney, Douglas W.

AU - Chavez, Julio

AU - Curtin, Peter

AU - Dinner, Shira

AU - Fynan, Thomas

AU - Gojo, Ivana

AU - Griffiths, Elizabeth A.

AU - Hough, Shannon

AU - Kloth, Dwight D.

AU - Kuter, David J.

AU - Lyman, Gary H.

AU - Mably, Mary

AU - Mukherjee, Sudipto

AU - Patel, Shiven

AU - Perez, Lia E.

AU - Poust, Adam

AU - Rampal, Raajit

AU - Roy, Vivek

AU - Rugo, Hope S.

AU - Saad, Ayman A.

AU - Schwartzberg, Lee

AU - Shayani, Sepideh

AU - Talbott, Mahsa

AU - Vadhan-Raj, Saroj

AU - Vasu, Sumithira

AU - Wadleigh, Martha

AU - Westervelt, Peter

AU - Burns, Jennifer L.

AU - Pluchino, Lenora

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.

AB - Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85038445478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038445478&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0175

DO - 10.6004/jnccn.2017.0175

M3 - Review article

VL - 15

SP - 1520

EP - 1541

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 12

ER -